|5.||Gastrointestinal Hemorrhage (Hematochezia)
|1.||Nishida, Norifumi: 3 articles (06/2015 - 09/2013)|
|2.||Yamamoto, Akira: 3 articles (06/2015 - 08/2011)|
|3.||Tanaka, Hiroaki: 2 articles (01/2014 - 04/2013)|
|4.||Hirakawa, Kosei: 2 articles (01/2014 - 01/2004)|
|5.||Poppenga, Robert H: 2 articles (12/2013 - 05/2005)|
|6.||Kim, Jae Woo: 2 articles (08/2013 - 05/2007)|
|7.||Leelakusolvong, Somchai: 2 articles (04/2013 - 08/2011)|
|8.||Matsumoto, Takayuki: 2 articles (09/2012 - 01/2004)|
|9.||Ashraf, Pervez: 2 articles (09/2011 - 09/2009)|
|10.||Shaikh, Hafeezullah: 2 articles (09/2011 - 09/2009)|
04/01/2015 - "Patients with melena, dark-red or maroon stool, hemodynamic instability, drop of hemoglobin level ≥2 g/dL/day, and/or need of transfusion ≥2 units of packed red blood cells per day were included. "
01/01/2015 - "A 50 year-old male presented with melena and hemoglobin concentration of 4.6g/dl. "
01/01/2014 - "A 55-year-old lady presented with recurrent episodes of melena and drop in hemoglobin. "
10/14/2013 - "However, the patient began passing melena after 3 d, with an acute decrease in hemoglobin levels. "
08/01/2013 - "Hemoglobin loss (≥2.0 g/dL) was observed in 20 patients, and melena developed in 1 patient after ESD. "
|2.||infliximab (Remicade)FDA Link
01/01/2012 - "Introduction of infliximab dramatically relieved the patient's melena and abdominal symptoms. "
01/01/2014 - "We report a case of common variable immune deficiency-related Crohn's-like disease presenting massive melena, which was successfully treated by short course infliximab therapy. "
|3.||Ganciclovir (Cytovene)FDA LinkGeneric
|4.||Thalidomide (Thalomid)FDA Link
|5.||Anti-Bacterial Agents (Antibiotics)IBA
07/01/2010 - "Between visits, patients were asked to report to the outpatient clinic if they had persistent ulcer or GI symptoms (dyspepsia, vomiting, nausea, heartburn, or acid regurgitation) not relieved by antacids for 1 week, or to the emergency department if they had evidence of GI bleeding or ulcer complications (melena, hematemesis, hematochezia, or sudden onset of severe epigastric pain). "
|8.||lenalidomide (CC 5013)FDA Link
09/01/2009 - "This is the case report of a 46-year-old female known case of Hepatitis C Virus (HCV) CLD, who presented with melena and coffee ground vomitings for 6 months. "
01/01/2008 - "Eighteen patients (0.4%) had a documented major UGIB (defined as evidence of melena, red or coffee-grounds emesis, blood per NG tube, or a decrease of Hgb by > 20 g/l and requiring a confirmation by endoscopy or radiological study). "
04/01/2011 - "All adult patients undergoing EGD for the indications of coffee-grounds vomitus, hematemesis or melena at a university hospital over an 18-month period were enrolled. "
12/01/2014 - "All consecutive patients aged ≥18 years who underwent esophagogastroduodenoscopy for the indications of coffee-grounds vomitus, hematemesis or melena with endoscopically diagnosed peptic ulcers were included. "
04/21/2013 - "The most common presentations were hematemesis (71.1%), melena (12.2%), and coffee ground emesis (8.9%). "
|10.||Urea (Carbamide)FDA LinkGeneric
04/01/2014 - "The significant predictors of adverse outcome were hemoglobin and systolic blood pressure in overall UGIB (p < 0.001), blood urea (p = 0.002), melena (p < 0.001) and syncope (p < 0.001) in variceal UGIB, and heart rate, melena, syncope and malignancy in non-variceal UGIB (p < 0.001). "
12/01/2013 - "A primary gastrointestinal loss of protein or blood was possible in a few cases, as evidenced by elevated blood urea nitrogen, anemia, intestinal parasitism, colitis, gastric hemorrhage, and melena. "
02/12/2007 - "The Rockall score and mBRS (hemoglobin level, hemodynamic instability, and presence of melena, liver disease, or cardiac failure; urea and syncope were not recorded) were calculated. "
03/01/2002 - "Based on the corresponding regression coefficients, the prognostic variables were classified as either major (shock, liver disease, anticoagulant therapy, urea/creatinine ratio > 62) or minor (hematocrit < 33%, renal failure, presentation as hematemesis and melenas, systolic arterial pressure < 110 mmHg, regular alcohol consumption, a history of UDB, and a patient age of > 75 years). "
10/01/1991 - "No adverse clinical signs or abnormal laboratory parameters were observed when serum ibuprofen concentrations were less than 31 micrograms/mL. Melena and 38 mg blood urea nitrogen/dL (normal 7-26 mg/dL) were present in an animal with a serum ibuprofen of 138 micrograms/mL."
|1.||Blood Transfusion (Blood Transfusions)
05/01/2000 - "Blood transfusions and arterial embolization were performed; however, continuous melena prevented improvement in their general condition. "
10/07/2015 - "A 50-year-old male immigrant from Ethiopia presented for consultation after 3 years of hematochezia/melena requiring > 25 units of blood transfusions. "
10/01/2015 - "Presenting symptoms were melena and hematochezia in the first 4 months of life (n = 14); several infants required multiple blood transfusions. "
01/01/2004 - "The patient was a 31-year-old-woman who had complained of melena and had severe anemia needing blood transfusion. "
01/01/2000 - "Following admission, she was treated conservatively at first, but melena continued and the anemia did not improve despite blood transfusions. "
|2.||Drug Therapy (Chemotherapy)
11/01/2013 - "[A case of melena and perforation during chemotherapy for peripheral T-cell lymphoma, not otherwise specified of the small intestine]."
03/01/1997 - "Six weeks after the start of chemotherapy, severe abdominal pain and melena occurred. "
07/01/1994 - "Severe abdominal pain and melena occurred one day after completion of the second course of chemotherapy. "
09/01/2009 - "We present a case of locally advanced duodenal adenocarcinoma that underwent radiotherapy and chemotherapy prior to presenting with massive upper gastrointestinal bleed as well as melena. "
03/01/1997 - "Four weeks after the start of chemotherapy, before intraarterial infusion of CDDP, she suffered from constipation and than diarrhea, abdominal pain and melena. "
01/01/2014 - "This report describes the successful use of portal venous stent placement for a patient with recurrent melena secondary to jejunal varices that developed after subtotal stomach preserved pancreatoduodenectomy (SSPPD). "
04/01/1999 - "Portal venous pressure significantly decreased from 25.3 +/- 7.4 mmHg to 22.4 +/- 6.6 mmHg (p < 0.0001) immediately after stent placement, leading to improvement in gastroesophageal varices, melena and ascites. "
01/01/2009 - "Unexplained melena associated with a history of endovascular stent grafting of abdominal aortic aneurysms: aortoduodenal fistula."
|4.||Enteral Nutrition (Feeding, Tube)